SOURCE: ThinkEquity Partners

April 19, 2006 13:46 ET

ThinkEquity Partners LLC Hosts a Panel Discussion on Ovarian Cancer Treatments

SAN FRANCISCO, CA -- (MARKET WIRE) -- April 19, 2006 -- ThinkEquity Partners LLC, a research-centric investment bank, announced today that it will host a forum led by members of its healthcare equity research team and industry experts to examine current ovarian cancer treatments.

The forum includes a distinguished team of doctors who will address current ovarian cancer treatments such as Doxil, Hycamptin and the platinums and experimental therapeutics in the clinic including TOCOSOL paclitaxel, Avastin and Telcyta. They will also speak about the current and future market opportunity for these therapies. Panel members include:

--  Dr. Allan Covens
    Gynecologic Oncology Site Group Leader, Toronto Sunnybrook Cancer
    Centre
    
--  Dr. Maurie Markman
    VP of Clinical Research, MD Anderson Cancer Center, Houston, TX
    
--  Dr. William McGuire
    University of Maryland, Franklin Square Hospital Center, Baltimore, MD
    
WHEN:     Friday, May 5, 2006
          11:30 AM-1:30 PM

WHERE:    The Ritz-Carlton New York, Central Park
More information about the event can be found at www.thinkequity.com

About ThinkEquity Partners LLC

ThinkEquity Partners LLC is a research-centric institutional investment bank focused on the growth economy. ThinkEquity Partners is dedicated to providing focused insight, advisory services, and capital to institutional investors and corporate constituents in the knowledge economy's key growth verticals, including technology, healthcare, media and consumer business services. For more information about ThinkEquity Partners, please visit www.thinkequity.com. Member NASD and SIPC.

Contact Information